USA flag logo/image

An Official Website of the United States Government

Search


Download to spreadsheetPrint
Displaying 476 – 500 of 719 Awards
Company: Physical Optics Corporation Agency/Program/Year/Phase: DOD / SBIR / 1994 / 1
Abstract: Currently, the United States Army is investigating the application of chemiluminescent and bioluminescent immunoassay technologies for biological agent detection. Immunoassays offer the potential of highly specific screening for diverse organic and inorganic… more
Company: Physical Optics Corporation Agency/Program/Year/Phase: DOD / SBIR / 1994 / 1
Abstract: … sensing technology under investigation at the U.S. Naval Research Laboratory. Optical fibers will be tapered to allow light to "leak out their sides," interacting with immunochemical detection layers bonded to their surfaces. Relatively standard fluorescence immunoassay… more
Company: Princeton Biomeditech Agency/Program/Year/Phase: HHS / SBIR / 1994 / 1
Abstract: … in TSH, this assay represents a significant technical innovation. Because of its low cost andease of use, it will have considerable commercial application as a replacement for more expensive andcumbersome radio-, enzyme-linked, fluorescent, and chemiluminescent immunoassays… more
Company: Research International, Inc Agency/Program/Year/Phase: DOD / SBIR / 1994 / 1
Abstract: N/A
Company: Sealite Sciences, Inc. Agency/Program/Year/Phase: HHS / SBIR / 1994 / 1
Abstract: Radioimmunoassays make up a significant percentage of the immunoassays used in clinicallaboratories. Nonradioactive, immunometric or "sandwich" assays using enzymes for signal generation(EIAs) have generally replaced radioimmunoassays for high molecular weight analytes. Low… more
Company: Tacan Corp Agency/Program/Year/Phase: NASA / SBIR / 1994 / 1
Abstract: … input light. including absorption and fluorescence, are detected by a photodiode array. Selection of the transducer in each of the matrix regions will enable measurement of temperature, mass flow rates, pH, and chemical concentrations in gaseous or liquid media. Immunoassay… more
Company: American Research Corporation of Virginia Agency/Program/Year/Phase: NSF / SBIR / 1993 / 1
Abstract: FIBER-OPTIC SENSORS, IN CONJUNCTION WITH FLUORESCENCE SPECTROSCOPY, HAS MANY USES IN BIOCHEMISTRY, IMMUNOASSAYS, AND CLOSED-AQUACULTURE SYSTEMS. THE USE OF IN SITU FLUORESCENCE MEASUREMENT DURING FIELD TESTS IS HAMPERED BY THE PHYSICAL LIMITATIONS OF SPECTROMETERS RELATED TO… more
Company: ANATRACE, INC. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 1
Abstract: …olerae (V. cholerae). Two major serotypes (Ogawa and Inaba) have been identified as defined by O antigens of lipopolysaccharide (LPS). Accurate serotyping and rapid identification of CT producing strains of V. cholerae by using monoclonal antibody based immunoassays are critical… more
Company: ANATRACE, INC. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 1
Abstract: … include the susceptibility of HIV-infected persons, the lack of rapid and effective diagnostic tests, and recent outbreaks of drug-resistant strains. The objective of this award is to produce monoclonal antibodies for the development of diagnostic immunoassays for… more
Company: Assay Research, Inc. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 2
Abstract: … EXIST FOR MONITORING HUMAN CYTOKINES, LITTLE OR NO ATTENTION HAS BEEN FOCUSED ON SUPPORTING BASIC CYTOKINE RESEARCH WITH ANALYTICAL SYSTEMS THAT EVALUATE MURINE CYTOKINES IN CULTURE MEDIA, AS WELL AS SERUM. THE SHORT-TERM GOAL IS TO DEVELOP AN ENZYME IMMUNOASSAY TO MEASURE… more
Company: Berkeley Antibody Company Agency/Program/Year/Phase: HHS / SBIR / 1993 / 2
Abstract: …HE PRESENTLY AVAILABLEASSAYS ARE NOT BETTER PREDICTORS OF TAMOXIFEN RESPONSIVENESS. IT IS THE GOAL OF THIS PROJECT TO GENERATE MONOCLONAL ANTIBODIES SPECIFIC FOR THESE VARIOUS ISOFORMS AND TO SUBSEQUENTLY UTILIZE THESE ANTIBODIES TO DEVELOP ISOFORM-SPECIFIC IMMUNOASSAYS FOR… more
Company: Berkeley Antibody Company Agency/Program/Year/Phase: HHS / SBIR / 1993 / 1
Abstract: … raised against an appropriately designed target structure (one that closely resembles the excited state emitter) may serve as a surrogate binding molecule. The resultant enhanced CL can then be extremely useful in a variety of applications, e. g. immunoassays. The… more
Company: SURMODICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 2
Abstract: … STEROIDS, IS THE GREAT UNLIKELIHOOD THAT ABUSERS WILL BE CAUGHT. DUE TO THE HIGH COSTS, TESTING IS INFREQUENT AND SPOTTY AT THE PROFESSIONAL AND COLLEGIATE LEVEL, AND NON-EXISTENT AT THE HIGH SCHOOL LEVEL. WE WILL DEVELOP AN INEXPENSIVE, RAPID EASY TO PERFORM ENZYME … more
Company: Bio-tek Instruments, Inc. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 1
Abstract: The overall objective is to develop highly stable electrochemical probes for the monitoring of the reduced cofactor nicotinamide adenine dinucleotide (NADH), which is produced in many enzyme-based immunoassays. These sensors can measure NADH concentrations at low applied… more
Company: Cellular Products, Inc. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 1
Abstract: A panel of "first generation" monoclonal antibodies (MAbs) has been developed which are directed to several distinct domains of the HTLV-1 surface protein. In addition, a sensitive chemiluminescent immunoassay has been constructed for the detection of HTLV-1 surface protein.… more
Company: ECOCHEM RESEARCH, INC. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 1
Abstract: N/A
Company: IMMTECH INTERNATIONAL, INC. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 2
Abstract: … USUALLY NOT AVAILABLE IN CLINICAL LABORATORIES, AND ARE EXPENSIVE TO PERFORM. THE PURPOSE OF THIS PROJECT IS TO DELINEATE THE MOLECULAR DIFFERENCE BETWEEN THE NATIVE (PI 5.4) AND THE PI 5.7-TRANSFERRIN ISOFORM. BASED UPON THE MOLECULAR DIFFERENCE, AN IMMUNOASSAY WILL BE… more
Company: Isolab, Inc. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 2
Abstract: …ANTITIES OF THE EMBRYONIC HEMOGLOBIN ZETA-CHAIN. THE GOAL OF THE FIRST PHASE OF THIS PROJECT IS THE DEVELOPMENT OF A HYBRIDOMA PRODUCING MONOCLONAL ANTIBODIES TO HEMOGLOBIN ZETA-CHAINS. WITH SUCH AN ANTIBODY IT WILL BE POSSIBLE TO THEN DEVELOP AN ENZYME-LINKED IMMUNOASSAY WITH… more
Company: Neogen Corporation Agency/Program/Year/Phase: USDA / SBIR / 1993 / 1
Abstract: NEOGEN CORPORATION HAS DEVELOPED NUMEROUS IMMUNOASSAYS CURRENTLY IN WIDE COMMERCIAL PRACTICE TO DETECT AND QUANTIFY TOXIC RESIDUES (E.G. MYCOTOXINS, SULFONAMIDES). TECHNOLOGY IS CURRENTLY BEING DEVELOPED FOR DETECTING AND QUANTIFYING THE DEVELOPMENTALLY REGULATED ENZYME… more
Company: ONCOGENE SCIENCE, INC. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 1
Abstract: …the worse the prognosis. What is unclear is whether overall kinase amplification or the levels of activated kinase provides the better prognostic indicator. The major difficulty is the ability to specifically measure activated kinases. We will develop a two-site immunoassay to… more
Company: OXFORD BIOMEDICAL RESEARCH, INC. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 1
Abstract: N/A
Company: Pharmingen Agency/Program/Year/Phase: HHS / SBIR / 1993 / 2
Abstract: … WAS ORIGINALLY THOUGHT TO BE A DOMINANT ONCOGENE. HOWEVER, RECENT DATA SUGGEST THAT P53 IS A TUMOR SUPPRESSOR GENE. MANY PROPERTIES OF P53 PROTEIN ARE SIMILAR TO THOSE OF THE PROTOTYPE TUMOR SUPPRESSOR RB PROTEIN. WE HAVE RECENTLY DEVELOPED ANTI-RB MAB-BASED IMMUNOASSAYS TO… more
Company: Pharmingen Agency/Program/Year/Phase: HHS / SBIR / 1993 / 1
Abstract: …for clinical applications. We will focus on the production and purification of full-length AR proteins from insect cells infected with baculovirus vector carrying the AR gene; these proteins will be used as immunogens to produce high affinity anti-AR mAbs and develop … more
Company: Physical Optics Corporation Agency/Program/Year/Phase: DOD / SBIR / 1993 / 1
Abstract: … interface to increase sensitivity to small amounts of target analytes. The proposed detection scheme allows the possibility of sensing multiple bioagents simultaneously with a single sensor unit. Using POC's "substrate mode" waveguide sensor, well-developed immunoassay… more
Company: Specialty Laboratories, Inc. Agency/Program/Year/Phase: HHS / SBIR / 1993 / 2
Abstract: … DILATED CARDIOMYOPATHY. MEASUREMENT OF BETA RECEPOR ACTIVITY RESTS PREDOMINANTLY ON THE BINDING ASSAY, WHICH HAS SEVERAL LIMITATIONS AND IS OF LIMITED CLINICAL UTILITY. THE GOAL IS TO PRODUCE SPECIFIC ANTIBODIES TO THE BETA ADRENERGIC RECEPTORS AND TO DEVELOP IMMUNOASSAYS… more
Displaying 476 – 500 of 719 Awards
Narrow Your Search
By Agency
By Year
By Phase
By Program
By State
By Company Ownership
By Company
HELP FOR NARROW YOUR SEARCH

Search Options

There are several categories such as “By Agency”, “By Year”, “By State” etc. Select a checkbox within a category to refine your search results.

Each of your selections is listed in the “Narrow Search Filters” bar. You can uncheck these selections to remove them.


Search for Either Criteria

When you select multiple values within a category, the results will include values that match either of the selections. For example, selecting “2005” and “2007” in the “By Year” category will display results that include either 2005 OR 2007 in the results.


Narrowing the Search Results

You can refine your search results across categories. To narrow down your results, select multiple values across different categories. The results will only include values that match the selections across the categories. For example, selecting “2005” in the “By Year” category and “NASA” in the “By Agency” category will only display the results that contain both “2005” AND “NASA” in the results.